InnoSIGN
Manufacturer of precision medicine for diagnostic and drug development applications
InnoSIGN has raised €7.3M across 1 funding round from 4 investors, most recently a Series A round in Apr 2022. Based in Eindhoven, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Eindhoven, Netherlandswww.innosignbio.com ↗
Total raised
€7.3M
€7,323,995
Funding rounds
1
Investors
4
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearInnoSIGN — funding by year — interactive chart.
Data table
| InnoSIGN — funding by year | |
|---|---|
| 2022 | €7.3M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-06 | Series A | €7.3M | Brabant Development Agency,Casdin Capital,Life Science Angels,Thuja Capital | View deal → |
Related news
- Dutch medtech startup InnoSIGN completes spin-out from Philips with €7.33M Series A financingsiliconcanals.com · 2022-04
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData